Michael Fossel

Michael B. Fossel, M.D., Ph.D. (born 1950, Greenwich, Connecticut) is a professor of clinical medicine at Michigan State University and editor of the Journal Of Anti-Ageing Medicine^[1] who is best known for his views on telomerase therapy as a possible treatment for cellular senescence. Fossel has appeared on many major news programs to discuss aging and appears regularly on National Public Radio (NPR). He is also a respected lecturer, author, and the founder and former editor-in-chief of the Journal of Anti-Aging Medicine (now known as Rejuvenation Research).

Prior to earning his M.D. at Stanford Medical School, Fossel earned a joint B.A. (cum laude) and M.A. in psychology at Wesleyan University and a Ph.D. in neurobiology at Stanford University. He is also a graduate of Phillips Exeter Academy. After graduating from medical school in 1981, he was awarded a National Science Foundation fellowship and taught at Stanford University.

In addition to his current position at Michigan State University, Fossel has lectured at the National Institute for Health, the Smithsonian Institution, and at various other universities and institutes in various parts of the world. Fossel is a fellow of the American College of Emergency Physicians, a member of the American Association for the Advancement of Science, the Gerontological Society of America, the American Society on Aging, and the American Geriatrics Society, and serves on the board of directors for the American Aging Association.

Fossel has written numerous articles on aging and ethics for the Journal of the American Medical Association and In Vivo, and a book by Fossel entitled Reversing Human Aging was published in 1996. The book garnered favorable reviews from mainstream newspapers as well as Scientific American and has since been published in six languages. An academic textbook by Fossel entitled Cells, Aging, and Human Disease was published in 2004 by Oxford University Press.

Since his days as a teacher at Stanford University, Fossel has studied aging from a medical and scientific perspective with a particular emphasis on premature aging syndromes such as progeria, and since at least 1996 he has been a strong and vocal advocate of experimenting with telomerase therapy as a way of treating diseases, disorders, and syndromes such as progeria, Alzheimer's disease, atherosclerosis, osteoporosis, cancer, AIDS, and organic senescence (i.e., aging). However, he is careful to qualify his advocacy of telomerase therapy as being a potential treatment for these conditions rather than a "cure for old age" and a panacea for age-related medical conditions, albeit a potential treatment that could radically extend the maximum human life span and reverse the aging process in most people. Specifically, Fossel sees the potential of telomerase therapy as being a highly effective point of intervention in a wide variety of medical conditions.

External links

• Michael Fossel's website

References

1. ^ "On the brink of immortality or the musings of madmen?". The Sydney Morning Herald. Archived from the original on 2009-03-08. http://www.webcitation.org/query?url=http%3A%2F%2Fwww.smh.com.au%2Fcgi-bin%2Fcommon%2FpopupPrintArticle.pl%3Fpath%3D%2Farticles%2F2004%2F03%2F06%2F1078464694855.html&date=2009-03-08. Retrieved 2009-03-08. ^{[dead link]}

Persondata
Name	Fossel, Michael
Alternative names
Short description
Date of birth	1950
Place of birth
Date of death
Place of death